Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation

ASAIO J. 2021 Feb 1;67(2):132-136. doi: 10.1097/MAT.0000000000001357.


There are limited data on the use of extracorporeal membrane oxygenation (ECMO) for pregnant and peripartum women with COVID-19 associated acute respiratory distress syndrome (ARDS). Pregnant women may exhibit more severe infections with COVID-19, requiring intensive care. We supported nine pregnant or peripartum women with COVID-19 ARDS with ECMO, all surviving and suffering no major complications from ECMO. Our case series demonstrates high-maternal survival rates with ECMO support in the management of COVID-19 associated severe ARDS, highlighting that these pregnant and postpartum patients should be supported with ECMO during this pandemic.

MeSH terms

  • Adult
  • COVID-19 / complications*
  • Critical Care
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Humans
  • Postpartum Period
  • Pregnancy
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / therapy*
  • SARS-CoV-2
  • Survival Rate
  • Young Adult